ReviewThe American journal of case reports2026
Endoscopic-Assisted Excision of Parotid Castleman Disease in Pediatric Patients: A Case Series of Three Patients and a Literature Review.
Review in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Castleman disease (CD) is a rare lymphoproliferative disorder, and parotid involvement in children is exceptionally uncommon. It is typically classified as unicentric (UCD) or multicentric; the hyaline vascular (HV) type is most prevalent. Surgical excision remains the standard curative treatment for UCD. CASE REPORT This study synthesizes recent advances in endoscopic-assisted excision of parotid CD among pediatric patients. We describe 3 pediatric patients (ages 2, 7, and 10 years) who presented with asymptomatic parotid masses, all initially misdiagnosed. Each patient underwent endoscopic-assisted resection via retroauricular or postauricular incisions to minimize visible scarring. Histopathologic evaluation confirmed HV-type UCD in all cases. No facial nerve injury occurred; all patients achieved uneventful recovery with no recurrence and excellent cosmetic results. A literature review of PubMed and Web of Science covering January 2000 to July 2025 identified 32 cases of parotid CD from 27 articles. HV-type UCD was predominant; 13 (40.6%) were pediatric cases, typically involving slow-growing, asymptomatic masses. Surgical excision was curative; conventional approaches often resulted in visible scars. Endoscopic-assisted techniques improved visualization, protected the facial nerve, and achieved superior cosmetic outcomes. Although infrequently reported in pediatric patients, our findings demonstrate that endoscopic-assisted parotidectomy is feasible and safe in this population. CONCLUSIONS Early diagnosis and prompt surgical excision are essential for pediatric parotid CD. HV-type UCD is most common, and prognosis is excellent after complete resection. Endoscopic-assisted surgery provides an effective, minimally invasive, and cosmetically favorable option for pediatric patients. Long-term follow-up remains important to detect rare recurrence or malignant transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.